Brignole C - Search Results

1

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Montaldo PG, Gambini C, Allen TM, Bogenmann E, Ponzoni M. Raffaghello L, et al. Among authors: brignole c. Int J Cancer. 2003 May 1;104(5):559-67. doi: 10.1002/ijc.10991. Int J Cancer. 2003. PMID: 12594810

2

In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.

Ribatti D, Raffaghello L, Pastorino F, Nico B, Brignole C, Vacca A, Ponzoni M. Ribatti D, et al. Among authors: brignole c. Int J Cancer. 2002 Dec 1;102(4):351-4. doi: 10.1002/ijc.10742. Int J Cancer. 2002. PMID: 12402304

3

Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region.

Banelli B, Casciano I, Croce M, Di Vinci A, Gelvi I, Pagnan G, Brignole C, Allemanni G, Ferrini S, Ponzoni M, Romani M. Banelli B, et al. Among authors: brignole c. Nat Med. 2002 Dec;8(12):1333-5; author reply 1335. doi: 10.1038/nm1202-1333. Nat Med. 2002. PMID: 12457155 No abstract available.

4

Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.

Pastorino F, Brignole C, Marimpietri D, Sapra P, Moase EH, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: brignole c. Cancer Res. 2003 Jan 1;63(1):86-92. Cancer Res. 2003. PMID: 12517782

5

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Bogenmann E, Ponzoni M, Montaldo PG. Raffaghello L, et al. Among authors: brignole c. Cancer Lett. 2003 Jul 18;197(1-2):151-5. doi: 10.1016/s0304-3835(03)00097-1. Cancer Lett. 2003. PMID: 12880975 Review.

6

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

Brignole C, Marimpietri D, Gambini C, Allen TM, Ponzoni M, Pastorino F. Brignole C, et al. Cancer Lett. 2003 Jul 18;197(1-2):199-204. doi: 10.1016/s0304-3835(03)00099-5. Cancer Lett. 2003. PMID: 12880982 Review.

7

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse.

Raffaghello L, Marimpietri D, Pagnan G, Pastorino F, Cosimo E, Brignole C, Ponzoni M, Montaldo PG. Raffaghello L, et al. Among authors: brignole c. Cancer Lett. 2003 Jul 18;197(1-2):205-9. doi: 10.1016/s0304-3835(03)00100-9. Cancer Lett. 2003. PMID: 12880983 Review.

8

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

Brignole C, Pagnan G, Marimpietri D, Cosimo E, Allen TM, Ponzoni M, Pastorino F. Brignole C, et al. Cancer Lett. 2003 Jul 18;197(1-2):231-5. doi: 10.1016/s0304-3835(03)00107-1. Cancer Lett. 2003. PMID: 12880987 Review.

9

Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.

Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: brignole c. Clin Cancer Res. 2003 Oct 1;9(12):4595-605. Clin Cancer Res. 2003. PMID: 14555535

10

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M. Pastorino F, et al. Among authors: brignole c. Cancer Res. 2003 Nov 1;63(21):7400-9. Cancer Res. 2003. PMID: 14612539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters